Peptide questions · Amycretin

How long does amycretin take to work?

Reviewed Evidence: ModeratePublished by PepVault

Amycretin’s onset is days–2 weeks, its peak effect comes at 36 weeks (longest trial so far), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

The timeline’s basis: Phase 1 and 1b/2a (Dahl 2025, Lancet; Gasiorek 2025, Lancet), phase 2 in type 2 diabetes (Mora 2026, Lancet, SubQ and oral), renal PK (Oldenburg 2026), Novo Nordisk report Feb-3-2026, AMAZE and AMBITION records on ClinicalTrials.gov. Investigational.

Amycretin week by week

The library places six of its research notes on amycretin on the days they cover, from day 1 to day 252 and on: 2 on randomized trials and 4 on clinical data.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The amycretin notes by day
WhenThe noteEvidence
Days 1–28 (weeks 1–4)A very low startRandomized trial
Days 57–140 (weeks 9–20)The lowest dose tested for weightClinical data
Days 85–252 (weeks 13–36)With type 2 diabetesRandomized trial
Days 113–196 (weeks 17–28)Five milligramsClinical data
Days 169–252 (weeks 25–36)Twenty milligramsClinical data
From day 253 onA long-term medicine, not a courseClinical data
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track amycretin in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The amycretin timeline’s milestones

The library’s timeline for amycretin marks 5 points from week 1 to week 36, backed by moderate evidence overall.

  • Week 1: Commonly reported: appetite dropping in the first days on the low start dose
  • Week 4: Its trials stepped the dose up every 4 weeks
  • Week 20: Phase 1b/2a: about 9.7% average loss at 1.25 mg after 20 weeks
  • Week 28: Phase 1b/2a: about 16% average loss at 5 mg after 28 weeks
  • Week 36: Phase 1b/2a: about 22% (20 mg) and 24% (60 mg) average loss vs about 2% on placebo

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why amycretin takes that long

Amycretin’s half-life is about 3.7 days (88 hours), so one dose is about 96.9% cleared after 18 days.

On its schedule (Weekly) the doses overlap, and the level of amycretin keeps climbing for about 15–18 days before it levels off, so the first 15–18 days run below the level the later weeks hold.

The notes on amycretin follow the trials’ dose steps, 1.25mg, 5mg and 20mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

Amycretin against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, amycretin among them; 15 of the others share its onset of days–2 weeks.

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people

Questions people ask

How long does amycretin take to work?

Amycretin’s onset is days–2 weeks, its peak effect comes at 36 weeks (longest trial so far), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

When does amycretin reach its peak effect?

By the library’s timeline, amycretin’s peak effect comes at 36 weeks (longest trial so far), backed by moderate evidence.

How long is amycretin usually run?

The library’s timeline gives amycretin’s typical duration as ongoing; its cycle note says: Used continuously, once weekly, in its trials: up to 36 weeks so far, with doses stepped up every 4 weeks.

What does the library say about the first days on amycretin?

Its first note on amycretin, for days 1–28 (weeks 1–4), is “A very low start”, resting on randomized trials.

More on amycretin

Track it in the app

PepVault for iPhone

Track amycretin in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo